Imatron CT Scanner Picked For NIH Cardiovascular Disease Screening Study
This article was originally published in The Gray Sheet
Executive Summary
Imatron says the selection of its Ultrafast electron beam computed tomography (EBCT) scanner by the National Heart, Lung and Blood Institute for an upcoming screening study cements the scanner's position as the "gold standard" for assessment of baseline cardiac risk.
You may also be interested in...
ACC/AHA EBT Findings Based On Inappropriate Comparison - Imatron, SAI
Imatron Inc. is critical of research methods the American College of Cardiology and the American Heart Association used to compile an expert consensus document concluding that electron beam computed tomography demonstrates roughly 70% accuracy in predicting cardiac conditions in symptomatic patients.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”